Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP: HOPHF )

0.2000 UNCHANGED
Last Price Updated: 10:11 AM EDT, May 17, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2000
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2000
Today's Range 0.2000 - 0.2000
52wk Range 0.2000 - 0.2000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option Grant
Via ACCESSWIRE

Performance

YTD
+700.00%
+700.00%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+700.00%
+700.00%
1 Year
+1318.44%
+1318.44%

More News

Read More
Hemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - HEMO-CAR-T First PQ Run Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Appointment of Director of Quality
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Approval and Issuance of Antibody Patent
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £4,056,250
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T 3rd Process Qualification Run Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple Viruses
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Appointment of Medical Director
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Development Runs Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Presentation at H.C. Wainwright Global Conference
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.